Deng Y, Huang W, Zeng T, Gao Y, et al. CDK4/6 inhibitors combined with fulvestrant for the treatment of HR+/HER2-advanced or metastatic breast cancer: a Bayesian network meta-analysis. BMC Cancer 2026 Feb 17. doi: 10.1186/s12885-026-15713.
PMID: 41703509